143 related articles for article (PubMed ID: 2731541)
21. Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline.
Hao NJ; Huang MP; Lee H
Mutat Res; 1995 May; 328(2):183-91. PubMed ID: 7739602
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines.
Hellmold H; Overvik E; Strömstedt M; Gustafsson JA
Carcinogenesis; 1993 Sep; 14(9):1751-7. PubMed ID: 8403195
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of the in vitro antimutagenic action of retinol.
Ioannides C; Ayrton AD; Keele A; Lewis DF; Flatt PR; Walker R
Mutagenesis; 1990 May; 5(3):257-62. PubMed ID: 2385179
[TBL] [Abstract][Full Text] [Related]
24. Effect of tryptamine on the mutagenic activity of 2-amino-3-methylimidazo(4,5-f) quinoline (IQ) and related azaarenes in the Ames test.
Abu-Shakra A; Ioannides C; Walker R
Mutagenesis; 1987 Jan; 2(1):51-6. PubMed ID: 3331694
[TBL] [Abstract][Full Text] [Related]
25. Induction of the hepatic mixed-function oxidases by Aroclor 1254 in the hamster: comparison of Aroclor-induced rat and hamster preparations in the activation of pre-carcinogens in the Ames test.
Hyde R; Smith JN; Ioannides C
Mutagenesis; 1987 Nov; 2(6):477-82. PubMed ID: 3127658
[TBL] [Abstract][Full Text] [Related]
26. Identification of new 2-amino-3-methylimidazo[4,5-f]quinoline urinary metabolites from beta-naphthoflavone-treated mice.
Lakshmi VM; Hsu FF; Zenser TV
Drug Metab Dispos; 2009 Aug; 37(8):1690-7. PubMed ID: 19451400
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
28. Contribution of DNA methylation and benzylation to N-nitroso-N-benzyl-methylamine-induced mutagenesis in bacteria: effects of rat liver cytochrome P450 isozymes and glutathione transferases.
Lin DX; Malaveille C; Park SS; Gelboin HV; Bartsch H
Carcinogenesis; 1990 Sep; 11(9):1653-8. PubMed ID: 2119260
[TBL] [Abstract][Full Text] [Related]
29. Induction and purification of cytochrome P450 1A1 from 3-methylcholanthrene-treated tilapia, Oreochromis niloticus x Oreochromis aureus.
Ueng YF; Ueng TH
Arch Biochem Biophys; 1995 Oct; 322(2):347-56. PubMed ID: 7574707
[TBL] [Abstract][Full Text] [Related]
30. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
[TBL] [Abstract][Full Text] [Related]
31. Bromopropylate: induction of hepatic cytochromes P450 and absence of covalent binding to DNA in mouse liver.
Thomas H; Sagelsdorff P; Molitor E; Skripsky T; Waechter F
Toxicol Appl Pharmacol; 1994 Nov; 129(1):155-62. PubMed ID: 7974489
[TBL] [Abstract][Full Text] [Related]
32. Effects of cigarette smoke and a heterocyclic amine, MeIQx on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver.
Mori Y; Koide A; Kobayashi Y; Furukawa F; Hirose M; Nishikawa A
Mutagenesis; 2003 Jan; 18(1):87-93. PubMed ID: 12473741
[TBL] [Abstract][Full Text] [Related]
33. Induction of the P-450 I family of proteins by polycyclic aromatic hydrocarbons: possible relationship to their carcinogenicity.
Ayrton AD; McFarlane M; Walker R; Neville S; Coombs MM; Ioannides C
Toxicology; 1990; 60(1-2):173-86. PubMed ID: 2315940
[TBL] [Abstract][Full Text] [Related]
34. Ahr locus phenotype in congenic mice influences hepatic and pulmonary DNA adduct levels of 2-amino-3-methylimidazo[4,5-f]quinoline in the absence of cytochrome P450 induction.
Nerurkar PV; Schut HA; Anderson LM; Riggs CW; Fornwald LW; Davis CD; Snyderwine EG; Thorgeirsson SS; Weber WW; Rice JM; Levy GN
Mol Pharmacol; 1996 May; 49(5):874-81. PubMed ID: 8622637
[TBL] [Abstract][Full Text] [Related]
35. Decreased hepatic microsomal cytochrome P450 due to indomethacin: protective roles of 16,16-dimethylprostaglandin F2 alpha and inducing agents.
Burke MD; Falzon M; Milton AS
Biochem Pharmacol; 1983 Feb; 32(3):389-97. PubMed ID: 6847694
[TBL] [Abstract][Full Text] [Related]
36. The mutagenicity and interactions of 2- and 4-(acetylamino)fluorene with cytochrome P450 and the aromatic hydrocarbon receptor may explain the difference in their carcinogenic potency.
Ioannides C; Cheung YL; Wilson J; Lewis DF; Gray TJ
Chem Res Toxicol; 1993; 6(4):535-41. PubMed ID: 8397005
[TBL] [Abstract][Full Text] [Related]
37. Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat.
Xu M; Bailey AC; Hernaez JF; Taoka CR; Schut HA; Dashwood RH
Carcinogenesis; 1996 Jul; 17(7):1429-34. PubMed ID: 8706244
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of inducers of cytochrome P450 on Mongolian gerbil and rat hepatic microsomal monooxygenase activities.
Fentem JH; Fry JR
Xenobiotica; 1991 Jul; 21(7):895-904. PubMed ID: 1776265
[TBL] [Abstract][Full Text] [Related]
39. The induction of P450 I proteins by aromatic amines may be related to their carcinogenic potential.
Ayrton AD; McFarlane M; Walker R; Neville S; Ioannides C
Carcinogenesis; 1990 May; 11(5):803-9. PubMed ID: 2335009
[TBL] [Abstract][Full Text] [Related]
40. Streptozotocin-induced diabetes modulates the metabolic activation of chemical carcinogens.
Ioannides C; Bass SL; Ayrton AD; Trinick J; Walker R; Flatt PR
Chem Biol Interact; 1988; 68(3-4):189-202. PubMed ID: 2975197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
